European Medicines Agency Approves Extended Shelf-life of up to 11 Months for the Johnson & Johnson COVID-19 Vaccine
- EMEA Innovative Medicine
- European Medicines Agency Approves Extended Shelf-life of up to 11 Months for the Johnson & Johnson COVID-19 Vaccine
European Medicines Agency Approves Extended Shelf-life of up to 11 Months for the Johnson & Johnson COVID-19 Vaccine
-
X (Twitter) -
LinkedIn -
Pinterest -
Copy link